Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > EBITDA Margin

Arbutus Biopharma Cp EBITDA Margin Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly EBITDA Margin from 2010 to 2017. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Arbutus Biopharma Cp EBITDA Margin for the quarter ending September 09, 2017 was $-142m a -71.85% increase of 102m year over year
  • Arbutus Biopharma Cp EBITDA Margin for the last 12 months ending June 06, 2016 was $-262m a 2.59% decrease of -7m year over year
  • Arbutus Biopharma Cp Annual EBITDA Margin for 2015 was $-146m a -48.38% increase of 71m from 2014
  • Arbutus Biopharma Cp Annual EBITDA Margin for 2014 was $-217m a 65.61% decrease of -142m from 2013
  • Arbutus Biopharma Cp Annual EBITDA Margin for 2013 was $-75m a -14.77% increase of 11m from 2012
Other Margins & Efficiency Metrics:
  • Arbutus Biopharma Cp Return on Capital % for the quarter ending December 12, 2018 was -19.07 a -3.10% increase of 0.59 year over year
  • Arbutus Biopharma Cp Return on Equity % for the quarter ending December 12, 2018 was -35.22 a 4.57% decrease of -1.61 year over year
View Chart On Koyfin

Quarterly ABUS EBITDA Margin Data

09/2017$-142m
12/2015$-38m
03/2015$-183m
12/2014$-244m
09/2014$-154m
03/2014$-131m
12/2013$-30m
09/2013$-118m
06/2013$-103m
03/2013$-133m

Annual ABUS EBITDA Margin Data

2015$-146m
2014$-217m
2013$-75m
2012$-86m
2011$-58m
2010$-26m
2009$-52m